Abstract 6046: Enhanced Acod1 expression in cancer cells promotes immune evasion
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-6046
Abstract: The monoclonal antibody αPD-1 used in immune checkpoint blockade (ICB) therapy has made a substantial impact in clinical outcomes for melanoma, lung, and breast cancer patients. Despite the success of ICB in these contexts, such… read more here.
Keywords: cell; cancer; icb; expression ... See more keywords